3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
18
Burkitt Lymphoma
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Smoldering Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Leukemia
2
Immunoglobulin Light-chain Amyloidosis
2
Down Syndrome
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Leukemia, Plasma Cell
1
Leukemia, Hairy Cell
1
Leukemia, Biphenotypic, Acute
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Brain Neoplasms
1
Anus Neoplasms
1
Ann Arbor Stage II Mantle Cell Lymphoma
1
Interventions
pembrolizumab
32
Paclitaxel
14
Carboplatin
12
Cisplatin
10
lenvatinib
7
Pemetrexed
6
belzutifan
4
Oxaliplatin
4
Gemcitabine
4
Fluorouracil
4
Capecitabine
4
Albumin-Bound Paclitaxel
4
patritumab deruxtecan
3
olaparib
3
Leucovorin
3
Docetaxel
3
Acetaminophen
3
130-nm albumin-bound paclitaxel
3
Levoleucovorin
2
Irinotecan
2
Histamine H2 Antagonists
2
Histamine Antagonists
2
Etoposide
2
Dexamethasone
2
Cetuximab
2
Bevacizumab
2
Axitinib
2
zanidatamab
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Calcium Dobesilate
×
30 days
×
Clear all
No trials found.